BBLG Q2 2020 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$132,709

Net Income

-$380,030

EPS (Diluted)

$-7.43

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$79,134

Free Cash Flow

-$79,130

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1,433

Total Liabilities

$13M

Stockholders' Equity

-$13M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$132,709	-$679,000	+80.5%
Net Income	-$380,030	-$926,000	+59.0%